Alnylam Pharmaceuticals
ALNY
#619
Rank
โ‚น3.975 T
Marketcap
โ‚น29,777
Share price
3.68%
Change (1 day)
7.58%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company